Immunovant EV 2011-2026 | IMVT

EV Jährlich Immunovant

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.61 B	3.5 B	2.59 B	2.16 B	59.6 M	717 M	-6.98 M	380 K	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
3.5 B	-6.98 M	1.33 B

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Assembly Biosciences ASMB	301 M	$ 28.49	0.11 %	$ 319 M	USA
Amphastar Pharmaceuticals AMPH	1.92 B	$ 19.61	0.59 %	$ 917 M	USA
Amarin Corporation plc AMRN	5.88 B	$ 14.72	1.59 %	$ 6.11 B	Irlanda
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Ascendis Pharma A/S ASND	849 M	$ 221.08	-0.36 %	$ 5 B	Danmark
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Autolus Therapeutics plc AUTL	1.11 B	$ 1.4	1.82 %	$ 357 M	Britain
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Axsome Therapeutics AXSM	8.95 B	$ 155.38	-0.98 %	$ 7.73 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
BioMarin Pharmaceutical BMRN	11.9 B	$ 55.05	1.7 %	$ 10.6 B	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	1.22 B	$ 3.46	1.76 %	$ 1.03 B	Canada
Benitec Biopharma BNTC	461 M	$ 10.92	-0.55 %	$ 449 M	USA
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	916 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Heron Therapeutics HRTX	411 M	$ 0.79	2.02 %	$ 132 M	USA
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	839 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	291 M	$ 2.13	2.15 %	$ 199 M	Israel
Coherus BioSciences CHRS	335 M	$ 1.58	3.62 %	$ 185 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	457 M	$ 4.47	5.54 %	$ 742 M	Canada
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	8.71 M	-	-5.98 %	$ 34.1 M	USA
Decibel Therapeutics DBTX	109 M	-	-	$ 123 M	USA